Eye, Ear & VisionDuring active treatment, RLRL was associated with less axial elongation than OK over 3 years in this cohort. Both treatments showed acceptable safety profiles.
Study · September 10, 2026 · Nie A et al.
Eye, Ear & VisionRLRL exerted refractive state-dependent effects on ocular growth in guinea pigs, attenuating myopic progression under myopic conditions and promoting refractive emmetropization under hyperopic conditions.
Study · August 12, 2026 · Liu T et al.
Devices & DosimetryNo adverse events were reported. MLS-based PBM was safe and associated with improvement in clinical signs of canine OE.
Study · August 3, 2026 · Gesuete F et al.
Eye, Ear & VisionRLRL slows ocular elongation and myopia progression. Recent studies provide reassuring evidence regarding its long-term safety when recommended treatment protocols are followed.
Review · July 10, 2026 · Domínguez-Morras C et al.
Eye, Ear & VisionCombining RLRL therapy with ortho-k is an effective and safe myopia control strategy in Caucasian Spanish children, supporting the potential generalisability of the synergistic effect across diverse ethnic groups.
Trial · June 22, 2026 · Fernández Fidalgo MJ et al.
Eye, Ear & VisionPBM significantly reduced drusen burden and improved visual function in early and intermediate dAMD over 12 months, with an excellent safety profile.
Study · June 8, 2026 · Iovino C et al.
Eye, Ear & VisionThe study indicates a seminal role of Beclin1 in maintaining retinal integrity and it defines the vulnerability of various retinal layers in the spreading of Beclin1-dependent retinal degeneration.
Study · May 4, 2026 · Biagioni F et al.
OtherAdjunctive LLLT was associated with a sustained increase in lipid layer thickness compared with IPL alone.
Trial · April 15, 2026 · Kharuhayothin C et al.